Alimera Sciences develops specialty ophthalmic pharmaceutical products for eye care providers and consumers.
- Sector: Biopharmaceuticals
- Investment Status: Alumni
- Year Funded: 2005
- NASDAQ: ALIM
Alimera Sciences develops specialty ophthalmic pharmaceutical products for eye care providers and consumers.
Helpful tips for managing kids' eye health. http://t.co/NS8evNWOBC
4:05pm May 17th from Alimera SciencesPredictors of DME identified. http://t.co/VlggCKTqPV
11:08am May 16th from Alimera SciencesNew stats shed light on diabetes epidemic. http://t.co/DFn8sgbo6B
2:18pm May 15th from Alimera SciencesNEI vodcast on diabetic eye disease to share with patients. http://t.co/WvNr0XHHzY
11:02am May 14th from Alimera SciencesInflammation needs to be addressed in chronic DME. http://t.co/6VUeJ4DtB1
3:47pm May 13th from Alimera SciencesAging eyes are more than wrinkles and crow’s feet. http://t.co/Qi6JlFT0DU
1:13pm May 13th from Alimera SciencesHow your brain tracks moving objects. http://t.co/ViwaD24J7X
1:51pm May 10th from Alimera Sciences